Royal Philips (NYSE:PHG) announced today that its Lumify with Reacts handheld tele-ultrasound imaging system is commercially available in Japan.
Japan’s healthcare authority cleared Lumify for compatible handheld devices in its healthcare market to make high-quality, portable ultrasound available almost everywhere in the country, according to a news release.
Lumify is designed for use in places where quick and easy access to diagnostic ultrasound imaging is required and is suitable for point-of-care use in hospitals, ambulances, doctor’s offices and patients’ homes during GP visits as well. It allows clinicians to remotely collaborate by sharing ultrasound images in real-time.
Amsterdam-based Philips also noted the value of Lumify as telehealth’s importance continues to grow amid the COVID-19 pandemic. Meanwhile, specific to Japan, which Philips said has a declining birthrate and aging population, the need for medical diagnostic e…